NEET PG exam: Mandaviya to felicitate top 25 rank holders each in medicine, dental courses – ET HealthWorld

New Delhi, Union Health Minister Mansukh Mandaviya will interact and felicitate top 25 rank holders in the NEET PG exam of both medicine and dental courses. This is first time that an Union Health minister will felicitate top rank holders of the entrance exam, officials said. The NEET PG-2022 results were declared on June 1. Mandaviya will also host a dinner for the top rank holders. Senior Health ministry officials will also be present on the occasion, they said. The event comes on the eve of the National Doctors’ Day…

Read More

France’s new wave of COVID infections expected to peak end-July -scientist – ET HealthWorld

Paris- A new wave in France of COVID-19 infections fuelled by emerging variants of the disease should peak towards end-July, the French government’s top scientific adviser Jean-Francois Delfraissy said on Thursday. “The peak is not yet here, this peak of infections will probably be for end-July,” Delfraissy told RTL radio. “Then the BA.5 variant will reappear, if it is not overtaken by another variant …in autumn,” he added. France reported new 124,724 coronavirus infections over the past 24 hours, against 77,967 a week ago. The French government also recommended this…

Read More

Pfizer signs new $3.2 bln COVID vaccine deal with U.S. government – ET HealthWorld

Pfizer Inc and partner BioNTech SE said on Wednesday they signed a $3.2 billion deal with the U.S. government for 105 million doses of their COVID-19 vaccine, which could be delivered as soon as later this summer. The deal includes supplies of a retooled Omicron-adapted vaccine, pending regulatory clearance, according to Pfizer. Drugmakers have been developing vaccines to target the Omicron variant that became dominant last winter. The average price per dose in the new deal is over $30, a more than 50% increase from the $19.50 per dose the…

Read More

WHO warns ‘sustained transmission’ of monkeypox risks vulnerable groups – ET HealthWorld

London – The World Health Organization said “sustained transmission” of monkeypox worldwide could see the virus begin to move into high-risk groups, like pregnant women, immunocompromised people and children. WHO said on Wednesday it is investigating reports of infected children, including two cases in the United Kingdom, as well as following up reports in Spain and France. None of the cases in children have been severe. The virus has now been identified in more than 50 new countries outside the countries in Africa where it is endemic. Cases are also…

Read More

India registers 18,819 new COVID-19 cases, active cases rise to 1,04,555 – ET HealthWorld

New Delhi: India’s COVID-19 vaccination coverage has exceeded 197.61 (1,97,61,91,554) crore. This has been achieved through 2,57,19,005 sessions. So far, more than 3.66 (3,66,66,548) crore adolescents have been administered the first dose of the COVID-19 vaccine. 13,827 patients have recovered in the last 24 hours and the cumulative tally of recovered patients is now at 4,28,22,493. Consequently, India’s recovery rate stands at 98.55 per cent. 18,819 new cases and 39 deaths were reported in the last 24 hours. India’s active caseload currently stands at 1,04,555. Active cases now constitute 0.24…

Read More

U.S. FDA classifies recall of GE’s ventilator batteries as most serious – ET HealthWorld

New York: U.S. health regulators on Tuesday classified the recall of some backup batteries of GE Healthcare‘s ventilators, which the company had initiated in mid-April, as the most serious type, saying that their use could lead to injuries or death. The CARESCAPE R860 ventilator’s backup batteries, including replacement backup batteries, were recalled as they were running out earlier-than-expected, which could cause the device to shut down preventing the patient from receiving breathing support, the U.S. Food and Drug Administration said. The CARESCAPE R860 ventilators use the main power via a…

Read More

Not every fever is Covid; swine flu and dengue on the prowl too: NIV – ET HealthWorld

Pune: Unlike the past three waves of the pandemic, when fever — in most cases — meant Covid, the current period is a mixed bag of seasonal viruses and SARS-CoV-2, experts have said. Scientists from ICMR-NIV said seasonal viruses, including H1N1 (swine flu) and H3N2, are now co-circulating with SARS-CoV-2. Dengue cases are also up, an NIV scientist said. “It’s an overlapping season of flu, SARS-CoV-2 and other respiratory viruses. Not every fever means Covid now. Our study clearly shows that,” the scientist said. Jehangir Hospital‘s infectious diseases expert Dr…

Read More

SKorea approves use of 1st homegrown COVID-19 vaccine from SK Bioscience – ET HealthWorld

Seoul: South Korea on Wednesday approved the use of SKYCovione, the country’s first homegrown COVID-19 vaccine developed by SK Bioscience Co., taking a major step toward achieving vaccine sovereignty in the fight against the pandemic. The Ministry of Food and Drug Safety (MFDS) said it approved the use of SKYCovione, also known as GBP510, through consultations of the ministry’s Final Inspection Committee, following an “item approval” recommendation by MFDS’ Central Pharmaceutical Affairs Council on Monday, Yonhap news agency reported. SKYCovione is the country’s first homegrown vaccine to have successfully completed…

Read More

Union government to soon make low-cost sanitary pads at South India Textile Research Association – ET HealthWorld

Coimbatore: The Union health ministry is planning to utilize the resources available with the South India Textile Research Association (Sitra) in the city to manufacture low-cost sanitary napkins. On Monday, Dr Prakash Vasudevan, director, Sitra, had met the health ministry officials in New Delhi to discuss the proceedings. Being the centre of excellence for medical textiles, Sitra has both the machinery and capacity to make more than one lakh sanitary napkins a day. “Union textiles minister Piyush Goyal was buoyed by the sanitary napkin manufacturing unit at Sitra during his…

Read More

NTAGI recommends vaccination against cervical cancer and Typhoid: Sources – ET HealthWorld

New Delhi: The government advisory panel NTAGI on Tuesday is learnt to have recommended vaccination against cervical cancer and typhoid after examining the data in this regard. The separately constituted HPV working group of NTAGI had on June 8 reviewed the clinical trial data and the usefulness of Serum Institute’s indigenously-developed and India‘s first Quadrivalent Human Papillomavirus vaccine (qHPV) against cervical cancer for inclusion in the National Immunization program, sources said. According to official sources, the subject expert committee of Central Drugs Standard Control Organisation (CDSCO) had on June 15…

Read More